Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1063354.RAIjTbwRY1UN4knpm3u7nLi-KowkCWSS_eR-RrbC-QNdI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1063354.RAIjTbwRY1UN4knpm3u7nLi-KowkCWSS_eR-RrbC-QNdI130_assertion type Assertion NP1063354.RAIjTbwRY1UN4knpm3u7nLi-KowkCWSS_eR-RrbC-QNdI130_head.
- NP1063354.RAIjTbwRY1UN4knpm3u7nLi-KowkCWSS_eR-RrbC-QNdI130_assertion wasGeneratedBy ECO_0000203 NP1063354.RAIjTbwRY1UN4knpm3u7nLi-KowkCWSS_eR-RrbC-QNdI130_provenance.
- NP1063354.RAIjTbwRY1UN4knpm3u7nLi-KowkCWSS_eR-RrbC-QNdI130_assertion wasDerivedFrom befree-2016 NP1063354.RAIjTbwRY1UN4knpm3u7nLi-KowkCWSS_eR-RrbC-QNdI130_provenance.
- NP1063354.RAIjTbwRY1UN4knpm3u7nLi-KowkCWSS_eR-RrbC-QNdI130_assertion SIO_000772 23527311 NP1063354.RAIjTbwRY1UN4knpm3u7nLi-KowkCWSS_eR-RrbC-QNdI130_provenance.
- NP1063354.RAIjTbwRY1UN4knpm3u7nLi-KowkCWSS_eR-RrbC-QNdI130_assertion evidence source_evidence_literature NP1063354.RAIjTbwRY1UN4knpm3u7nLi-KowkCWSS_eR-RrbC-QNdI130_provenance.
- NP1063354.RAIjTbwRY1UN4knpm3u7nLi-KowkCWSS_eR-RrbC-QNdI130_assertion description "[FGFR2 and FGF10, the main ligand of FGFR2, are both overexpressed in 5-10% of breast tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1063354.RAIjTbwRY1UN4knpm3u7nLi-KowkCWSS_eR-RrbC-QNdI130_provenance.